AI English summary of an SEC filing — figures as filed
Edwards Lifesciences EWEdwards Lifesciences said it appointed David T. Feinberg, M.D. to its Board of Directors, effective immediately, on July 10, 2024. The Board also appointed Feinberg to serve on the Audit Committee.
Key points
AI summaryEdwards Lifesciences said it appointed David T. Feinberg, M.D. to its Board of Directors, effective immediately, on July 10, 2024. The Board also appointed Feinberg to serve on the Audit Committee.
The company said Feinberg, who is 62 years old, has served as Chairman of Oracle Health since 2022, and was CEO of Cerner Corporation from 2021 to 2022. It also said he was Vice President of Google Health from 2019 to 2021.
The company said Feinberg was President and CEO of Geisinger Health, and from 2008 to 2015 held roles at UCLA, including President and CEO of UCLA Health, and that he currently serves on the Humana board. It cited the following education: a bachelor's degree in economics from the University of California at Berkeley, an M.D. from Chicago Medical School, and an MBA from Pepperdine University.
The company said there is no arrangement or understanding with any other person under which Feinberg was selected as a director, and that he has no material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K. His compensation will be the pro rata amount of non-employee director pay described in the 2024 Proxy Statement. The company also said it will enter into its standard indemnification agreement with him.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Feinberg Appointed to Board and Audit Committee
Edwards Lifesciences said it appointed David T. Feinberg, M.D. to its Board of Directors, effective immediately, on July 10, 2024. The Board also appointed Feinberg to serve on the Audit Committee.
Source · Based on the filing body and exhibits
Feinberg's Key Career Experience
The company said Feinberg, who is 62 years old, has served as Chairman of Oracle Health since 2022, and was CEO of Cerner Corporation from 2021 to 2022. It also said he was Vice President of Google Health from 2019 to 2021.
Source · Based on the filing body and exhibits
Feinberg's Other Board Roles and Education
The company said Feinberg was President and CEO of Geisinger Health, and from 2008 to 2015 held roles at UCLA, including President and CEO of UCLA Health, and that he currently serves on the Humana board. It cited the following education: a bachelor's degree in economics from the University of California at Berkeley, an M.D. from Chicago Medical School, and an MBA from Pepperdine University.
Source · Based on the filing body and exhibits
Feinberg Appointment Terms, Compensation and Indemnification
The company said there is no arrangement or understanding with any other person under which Feinberg was selected as a director, and that he has no material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K. His compensation will be the pro rata amount of non-employee director pay described in the 2024 Proxy Statement. The company also said it will enter into its standard indemnification agreement with him.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…